Skip Ribbon Commands
Skip to main content
Menu
Dr Tan Yan Chin

Dr Tan Yan Chin

​MD(UKM), MMed(NUS), MRCP(UK), FRCPath(UK)

Associate Consultant

Sengkang General Hospital

Specialty: Haematology

Conditions Treated by this Doctor:
Acute Leukaemia, Aplastic Anaemia, Chronic Myeloid Leukaemia, Essential Thrombocythemia and Myelofibrosis, Haemophilia and other bleeding disorders, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Polycythemia Vera, Thalassemia, Thrombosis (Clotting Disorders), Venous Thromboembolism.

Clinical Appointments

  • Associate Consultant Haematology Service Sengkang General HospitalSengkang General Hospital
  • Associate Consultant Department of General Medicine Sengkang General HospitalSengkang General Hospital
  • Associate Consultant Haematology Singapore General HospitalSingapore General Hospital
  • Associate Consultant Haematology Myeloma National Cancer Centre SingaporeNational Cancer Centre Singapore

Profile

Dr Tan Yan Chin received her medical education at the National University of Malaysia. After her graduation from medical school, she received her junior residency training in internal medicine in Singapore. She subsequently completed her senior residency training in Haematology in 2021. She is currently providing her service in Seng Kang General Hospital (SKH), Singapore General Hospital (SGH), National Cancer Center, as well as Health Sciences Authority Singapore (HSA)

Education

Professional Appointments and Committee Memberships

  • Clinical instructor- Duke-NUS Medical School
  • Clinical tutor- Yong Loo Lin School of Medicine, NUS
  • Clinical instructor- Duke-NUS Medical School
  • Clinical tutor- Yong Loo Lin School of Medicine, NUS
  • Member of Blood transfusion Committee Seng Kang General Hospital (SKH)
  • Associate Consultant Haematology National Cancer Center Singapore
  • Associate Consultant Blood Service Group, Health Sciences Authority, Singapore

Awards

Singapore Health Quality Service Awards (Silver) 2022

Research Interests

Publications

  1. Ong SY, de Mel S, Grigoropoulos NF, Chen Y, Tan YC, Tan MSY, et al. High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma. Blood Cancer J [Internet]. 2021 Aug 12;11(8):143
  2. Bryan M H Keng, Zhi Xuan Ng, Yan Chin Tan, Thuan Tong Tan, Gee Chuan Wong, Chandramouli Nagarajan. Surgical management of invasive fungal infections in adult leukemia patients: experience from a large tertiary center in Southeast-Asia. Blood Sci 2019 Aug 1;2(2):59-65. doi: 10.1097/BS9.0000000000000022.

Research Trials